• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIPK1与c-Myb相互作用,并通过磷酸化调节其活性。

HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.

作者信息

Matre Vilborg, Nordgård Oddmund, Alm-Kristiansen Anne Hege, Ledsaak Marit, Gabrielsen Odd Stokke

机构信息

Department of Molecular Biosciences, University of Oslo, Norway.

出版信息

Biochem Biophys Res Commun. 2009 Oct 9;388(1):150-4. doi: 10.1016/j.bbrc.2009.07.139. Epub 2009 Jul 30.

DOI:10.1016/j.bbrc.2009.07.139
PMID:19646965
Abstract

The transcription factor v-Myb is a potent inducer of myeloid leukaemias, and its cellular homologue c-Myb plays a crucial role in the regulation of haematopoiesis. In a yeast two-hybrid (Y2H) screening we identified the nuclear kinase HIPK1 as an interaction partner for human c-Myb. The interaction involves a C-terminal region of HIPK1, while a bipartite interaction surface was identified in c-Myb, including regions in its N-terminal DNA-binding domain as well as in its C-terminal region. HIPK1 and c-Myb co-localize in distinct nuclear foci upon co-transfection. c-Myb appears to be phosphorylated by HIPK1 in its negative regulatory domain as supported by both in vivo and in vitro data. A functional assay revealed that HIPK1 repressed the ability of c-Myb to activate a chromatin embedded target gene, mim-1, in haematopoetic cells. Our findings point to a novel link between an important kinase and a key regulator of haematopoiesis.

摘要

转录因子v-Myb是髓系白血病的强效诱导剂,其细胞同源物c-Myb在造血调控中起关键作用。在酵母双杂交(Y2H)筛选中,我们鉴定出核激酶HIPK1是人c-Myb的相互作用伴侣。这种相互作用涉及HIPK1的C末端区域,而在c-Myb中鉴定出一个二分相互作用表面,包括其N末端DNA结合结构域以及C末端区域中的区域。共转染后,HIPK1和c-Myb在不同的核灶中共定位。体内和体外数据均支持c-Myb在其负调控结构域中似乎被HIPK1磷酸化。功能分析表明,HIPK1抑制了c-Myb在造血细胞中激活染色质嵌入靶基因mim-1的能力。我们的发现指出了一种重要激酶与造血关键调节因子之间的新联系。

相似文献

1
HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.HIPK1与c-Myb相互作用,并通过磷酸化调节其活性。
Biochem Biophys Res Commun. 2009 Oct 9;388(1):150-4. doi: 10.1016/j.bbrc.2009.07.139. Epub 2009 Jul 30.
2
FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.FLASH作为转录因子c-Myb的共激活因子,并定位于活跃的RNA聚合酶II位点。
Oncogene. 2008 Aug 7;27(34):4644-56. doi: 10.1038/onc.2008.105. Epub 2008 Apr 14.
3
c-Myb protein interacts with Rcd-1, a component of the CCR4 transcription mediator complex.c-Myb蛋白与Rcd-1相互作用,Rcd-1是CCR4转录调节复合物的一个组成部分。
Biochemistry. 2004 Jun 29;43(25):8152-9. doi: 10.1021/bi035857y.
4
BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.BS69是一种腺病毒E1A相关蛋白,可抑制c-Myb的转录活性。
Oncogene. 2001 Jan 4;20(1):125-32. doi: 10.1038/sj.onc.1204048.
5
Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.HIPK1和HIPK2在AML1和p300依赖性转录、造血及血管形成中的作用
EMBO J. 2006 Sep 6;25(17):3955-65. doi: 10.1038/sj.emboj.7601273. Epub 2006 Aug 17.
6
The adaptor protein ARA55 and the nuclear kinase HIPK1 assist c-Myb in recruiting p300 to chromatin.衔接蛋白 ARA55 和核激酶 HIPK1 协助 c-Myb 将 p300 募集到染色质上。
Biochim Biophys Acta Gene Regul Mech. 2017 Jul;1860(7):751-760. doi: 10.1016/j.bbagrm.2017.05.001. Epub 2017 May 8.
7
Constitutive c-Myb amino-terminal phosphorylation and DNA binding activity uncoupled during entry and passage through the cell cycle.在细胞周期进入和进程中,组成型c-Myb氨基末端磷酸化与DNA结合活性解偶联。
Oncogene. 2001 Mar 29;20(14):1784-92. doi: 10.1038/sj.onc.1204345.
8
Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.c-Myb 多个结构域的突变破坏了与 CBP/p300 的相互作用,并消除了髓系转化能力。
Mol Cancer Res. 2009 Sep;7(9):1477-86. doi: 10.1158/1541-7786.MCR-09-0070. Epub 2009 Sep 8.
9
c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro.在体外,c-Myb和v-Myb被p42丝裂原活化蛋白激酶磷酸化的情况不同。
Oncogene. 1993 Aug;8(8):2259-65.
10
Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.组蛋白H3尾巴的定位及乙酰化作用由c-Myb而非v-Myb的DNA结合SANT结构域介导。
Genes Dev. 2005 Oct 15;19(20):2447-57. doi: 10.1101/gad.355405. Epub 2005 Sep 29.

引用本文的文献

1
The multifaceted roles of Myb domain-containing proteins in apicomplexan parasites.Myb 结构域蛋白在顶复门寄生虫中的多效性作用。
Curr Opin Microbiol. 2023 Dec;76:102395. doi: 10.1016/j.mib.2023.102395. Epub 2023 Oct 30.
2
HIPK1 Inhibition Protects against Pathological Cardiac Hypertrophy by Inhibiting the CREB-C/EBPβ Axis.HIPK1 抑制通过抑制 CREB-C/EBPβ 轴保护病理性心肌肥厚。
Adv Sci (Weinh). 2023 Jun;10(18):e2300585. doi: 10.1002/advs.202300585. Epub 2023 Apr 26.
3
Improved protein expression in HEK293 cells by over-expressing miR-22 and knocking-out its target gene, HIPK1.
通过过表达 miR-22 和敲除其靶基因 HIPK1 提高 HEK293 细胞中的蛋白质表达。
N Biotechnol. 2020 Jan 25;54:28-33. doi: 10.1016/j.nbt.2019.08.004. Epub 2019 Aug 16.
4
The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression.SUMO 蛋白酶 SENP1 和染色质重塑酶 CHD3 相互作用,并共同影响染色质可及性和基因表达。
J Biol Chem. 2018 Oct 5;293(40):15439-15454. doi: 10.1074/jbc.RA118.002844. Epub 2018 Aug 6.
5
Identifying HIPK1 as Target of miR-22-3p Enhancing Recombinant Protein Production From HEK 293 Cell by Using Microarray and HTP siRNA Screen.通过微阵列和高通量 siRNA 筛选鉴定 HIPK1 为 miR-22-3p 增强 HEK 293 细胞中重组蛋白生产的靶标。
Biotechnol J. 2018 Feb;13(2). doi: 10.1002/biot.201700342. Epub 2017 Nov 14.
6
Identification of c-Myb Target Genes in K562 Cells Reveals a Role for c-Myb as a Master Regulator.K562细胞中c-Myb靶基因的鉴定揭示了c-Myb作为主要调控因子的作用。
Genes Cancer. 2011 Aug;2(8):805-17. doi: 10.1177/1947601911428224.
7
PIAS1 interacts with FLASH and enhances its co-activation of c-Myb.PIAS1 与 FLASH 相互作用,并增强其对 c-Myb 的共激活作用。
Mol Cancer. 2011 Feb 21;10:21. doi: 10.1186/1476-4598-10-21.
8
Myb proteins: angels and demons in normal and transformed cells.Myb 蛋白:正常和转化细胞中的天使与恶魔。
Front Biosci (Landmark Ed). 2011 Jan 1;16(3):1109-31. doi: 10.2741/3738.